The big volume day 11/21 on no news, actually there was news. I don't see it posted. So here it is. Sorry I don't monitor every day.
VCEL, SNY 11/21 Vericel higher after CareFirst deems ACI medically necessary CareFirst announced yesterday in a medical policy bulletin that autologous chondrocyte implantation for the treatment of full-thickness articular cartilage defects of the knee as a result of acute or repetitive trauma is considered medically necessary when certain conditions are met. The culturing of chondrocytes is subject to a biologic licensing requirement by the FDA. Carticel from Sanofi's (SNY) Genzyme unit and MACI from Vericel (VCEL) have received FDA approval for the culturing of chondrocytes through a biologics license for specific indications. Shares of Vericel are up 40c to $4.25 in afternoon trading. Reference Link